24th marzo 2020
Últimas noticias
Encuentre cualquiera de nuestros más recientes comunicados de prensa, manténgase actualizado con las últimas noticias e infórmese sobre los próximos eventos a los que acudirá Curium.
20th marzo 2020
Un mensaje de Curium sobre el COVID-19 y nuestras acciones
12th marzo 2020
RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA
3rd marzo 2020
Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio
30th enero 2020
Curium is attending these global congresses in 2020
7th enero 2020
RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application
2nd diciembre 2019
Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
16th noviembre 2019
CEO Today Healthcare Awards Winner 2019
13th noviembre 2019
Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S.
4th septiembre 2019
Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)
22nd febrero 2019
Curium is attending these global congresses in 2019
13th febrero 2019
Campaign to Support FDA Approved Products
5th febrero 2019
Curium Petten and NRG Agreement
6th septiembre 2018
Renaud Dehareng de Curium recibe el galardón CEO Healthcare Award 2018
27th agosto 2018
Curium y RadioMedix anuncian un acuerdo global en exclusiva para el desarrollo de 64Cu-Dotatate
10th mayo 2018
Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas
2nd mayo 2018
Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations
11th abril 2018
Curium adquiere las operaciones comerciales y de fabricación de Cyclopharma en Francia.
26th marzo 2018
Moving on from Mallinckrodt: Curium eyes $650 million in radiopharmaceuticals sales
10th febrero 2018